Clinical Trials Logo

Filter by:
NCT ID: NCT04258267 Recruiting - Clinical trials for Arthroplasty, Replacement, Shoulder

Which Factors Influence the Outcome After Anatomical and Reverse Shoulder Arthroplasty?

FINOSA
Start date: January 14, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to investigate pre-, intra- and post-operative factors that influence post-operative outcome (shoulder pain, shoulder function and quality of life) after shoulder arthroplasty.

NCT ID: NCT04257461 Recruiting - Clinical trials for Small Bowel Adenocarcinoma

A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma

BALLAD
Start date: February 20, 2020
Phase: Phase 3
Study type: Interventional

An open-label, randomised, controlled, multi-centre, trial with disease free survival as the primary end point. The worldwide collaboration is referred to as GLOBAL BALLAD and consists of a number of individual parallel prospective studies addressing the same objectives with similar designs brought together under the framework of the International Rare Cancer Initiative. This protocol is for BALLAD BELGIUM, which is the component of GLOBAL BALLAD.

NCT ID: NCT04253327 Recruiting - Clinical trials for Ovarian Neoplasm Epithelial Borderline

Distress, Anxiety and Psychosexual Health in BOT

Start date: September 1, 2020
Phase:
Study type: Observational

The aim of this study is to assess the prevalence of distress, anxiety and psychosexual anguish in patients diagnosed with borderline ovarian tumor (BOT) compared to controls confronted with surgical treatment for benign ovarian tumors.

NCT ID: NCT04251572 Recruiting - Drug Use Clinical Trials

HCV Reinfection After DAA Therapy in PWID in Belgium

REINF_HCV
Start date: July 1, 2019
Phase: N/A
Study type: Interventional

The primary aim of this study is to calculate the incidence of HCV reinfection after successful DAA treatment among people who have recently injected drugs. The secondary aim is to identify factors associated with reinfection in this population. Individuals with active injecting drug abuse with a chronic HCV infection who have achieved end of treatment response (ETR; defined as non-detectable HCV RNA at end of treatment) to any interferon-free DAA combination will be included in this multicenter interventional study.

NCT ID: NCT04250155 Recruiting - Solid Tumors Clinical Trials

An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Start date: March 9, 2020
Phase: Phase 1
Study type: Interventional

This study will evaluate the safety, tolerability, pharmacokinetics, and activity of XmAb24306 alone or in combination with a checkpoint inhibitor treatment in participants with locally advanced or metastatic solid tumors.

NCT ID: NCT04249102 Recruiting - Type 1 Diabetes Clinical Trials

Prospective Randomized Clinical Trial Assessing the Short Term Clinical Impact of Continuous vs Flash Glucose Monitoring in Children, Adolescents and Young Adults With Type 1 Diabetes

GluMoCAY
Start date: March 12, 2020
Phase: N/A
Study type: Interventional

Impaired hypoglycemia awareness, a significant problem for children with type 1 diabetes, is defined as neurogenic symptom response before autonomic response to hypoglycemia. Avoiding hypoglycemia appears to restore hypoglycemia awareness. Investigators have previously demonstrated in a retrospective study that Flash Glucose Monitoring system decreased the risk of severe hypoglycemia in type 1 diabetic children and adolescents, even though Flash Glucose Monitoring system, unlike Continuous Glucose Monitoring system, does not provide glucose alerts. Continuous Glucose Monitoring system, by providing real-time data with alarms, could benefit to subjects still experiencing severe hypoglycemia with Flash Glucose Monitoring system. Besides, in adults, Continuous Glucose Monitoring system reduced more effectively impaired hypoglycemia awareness compared to Flash Glucose Monitoring system. In that context, investigators would like to assess the impact of Continuous Glucose Monitoring system instead of Flash Glucose Monitoring system on hypoglycemia in children and adolescents with type 1 diabetes.

NCT ID: NCT04246515 Recruiting - Hamstring Injury Clinical Trials

The Effect of Blood Flow Restriction Training on Hamstring Elasticity After Injury

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effect of Blood Flow Restriction Training on the elasticity of the hamstring muscle after an acute injury. Therefore a group of football players with a recent hamstring strain injury (HSI) will be recruited and randomly assigned in one of the three following groups: Experimental group: Classic rehabilitation + Blood Flow Restriction Training Sham group: Classic rehabilitation + sham Blood Flow Restriction Training Control group: Classic rehabilitation The study procedure will be as followed: 1. HSI (onset) -> recruitment via football clubs, physiotherapy practices, leaflets,… 2. MRI scan (day 0-4) -> injury location, grade and extend (The British Athletics Medical Team Classification) 3. Shear Wave Elastography (SWE) measurement (day 0-4) of the injured site and the exact same location at the contralateral leg. 4. Rehabilitation in one of the three groups + Testing At the first therapy session a standardized initial assessment sheet will be filled in comprising of all the necessary information regarding patient information and history (recent hamstring injury and past injuries) . Furthermore, a weekly assessment of the strongest predictors of rehabilitation duration will be conducted. Between day 12 and 16 a second shear wave elastographic measurement will be performed. 5. Return to play (RTP) The RTP decision will be made by the head physician and the attending physiotherapist. The decision will be based on clearly predefined criteria. At moment of RTP a third shear wave elastographic measurement will be performed. 6. Follow-up The football players will be contacted regularly by phone to inquire about possible re-injuries, this for a period of 6 months after injury onset. At week 12 after injury onset, a fourth and last shear wave elastographic measurement will be performed. The evolution of the hamstring elasticity and other outcome measures will be compared between groups and also within groups between the injured leg and the healthy contralateral leg.

NCT ID: NCT04246463 Recruiting - Surgery Clinical Trials

Terumo Aortic Global Endovascular Registry

TiGER
Start date: December 17, 2019
Phase:
Study type: Observational

Multi-arm, multi-center, open label, prospective observational registry designed to obtain safety and performance data on the use of CE marked and custom Terumo Aortic endovascular grafts.

NCT ID: NCT04243499 Recruiting - Solid Tumor, Adult Clinical Trials

First-in-Human Study of ICT01 in Patients With Advanced Cancer

EVICTION
Start date: February 10, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Part 1 will be a dose escalation study of IV ICT01 (a monoclonal antibody targeting BTN3A) as monotherapy in patients with advanced solid or hematologic tumors, followed by a cohort examining the combination of ICT01 plus pembrolizumab (Keytruda). Part 2 will be a cohort expansion into 2 solid tumor indications and one hematologic malignancy for ICT01 monotherapy, and 3 solid tumor indications for the combination of ICT01 plus pembrolizumab.

NCT ID: NCT04242017 Recruiting - Prostate Cancer Clinical Trials

Long-term Better Than Short-term ADT With Salvage RT

LOBSTER
Start date: July 7, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

A randomized, multicenter, prospective PHASE II trial to assess the effect of short- versus long-term adjuvant ADT with high dose salvage radiotherapy on distant metastasis free survival in case of biochemical relapse (BR) after radical prostatectomy.